Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Spot On Sciences Launches Searchable Database of Dried Blood Spot Methods

Published: Friday, September 07, 2012
Last Updated: Friday, September 07, 2012
Bookmark and Share
Spot On Science’s free, publicly accessible database aids researchers by providing rapid access to published dried blood spot (DBS) test methods.

Spot On Sciences, Inc., an Austin-based medical device company, has just released a web-based searchable database that focuses exclusively on advances made in dried blood spot (DBS) methods and technology over the last 40 years. The database, the first and only one currently accessible to the public, is designed to help advance DBS adoption and assist bioscience researchers with work being done in diagnostic testing and medical research. Recent advances in DBS technology have elevated its value both as a sampling tool and vital component of laboratory analysis.

"Those of us in interested in DBS have been waiting for this type of research tool for a long time” said Dr. John Repass, former research scientist at M.D. Anderson Cancer Center and current Chief Scientist at ARQ Genetics. “This database allows an easier way for me to search and navigate through the myriad of studies scattered over hundreds of sources. It’s a great time-saver for anyone doing research and developing DBS methods.”

Spot On Sciences, Inc.’s CEO, Dr. Jeanette Hill, explained that “there’s been an explosion of methods and papers devoted to DBS and we detected the need within the bioscience community for this type of site-based resource. Anyone can come to our site and can browse by analyte or keywords to track down key information from over 1,000 entries.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Potential “Good Fat” Biomarker
New method to measure the activity of energy consuming brown fat cells could ease the testing weight loss drugs.
MicroRNA Pathway Could Lead to New Avenues for Leukemia Treatment
Cancer researchers at the University of Cincinnati have found a particular signaling route in microRNA (miR-22) that could lead to targets for acute myeloid leukemia, the most common type of fast-growing cancer of the blood and bone marrow.
Soy Shows Promise as Natural Anti-Microbial Agent
Soy isoflavones and peptides may inhibit the growth of microbial pathogens that cause food-borne illnesses, according to a new study from University of Guelph researchers.
Doubling Down on Dengue
HMS researchers have discovered two ways a compound blocks dengue virus.
Soy Shows Promise as Natural Anti-Microbial Agent
Researchers from University of Guelph show that soy isoflavones and peptides could be used to reduce microbial contamination of food.
AstraZeneca to Sequence 2 Million Genomes in Search for New Drugs
Company launches integrated genomics approach which aims to transform drug discovery and development.
Unique Model for Studying ALS
Unique mouse model will allow researchers to better study the genetic origins and potential treatments of ALS.
Targeting an ‘Undruggable’ Cancer Gene
RAS genes are mutated in more than 30 percent of human cancers and represent one of the most sought-after cancer targets for drug developers.
Biomarkers for Profiling Prostate Cancer Patients
Exiqon A/S has announced the publication of validation of prognostic microRNA biomarkers for the aggressiveness of prostate cancer in independent cohorts.
Improving Engineered T-Cell Cancer Treatment
Purdue University researchers may have figured out a way to call off a cancer cell assassin that sometimes goes rogue and assign it a larger tumor-specific "hit list."
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!